Minerva Neurosciences (NERV)

• Market cap: $15.8M
• 1 day: 0.44%
• 5 days: 3.20%
• 1 month: -2.59%
• 3 months: -14.72%
• 6 months: -21.80%
• Year to date: -63.25%
• 1 year: -65.28%
• 5 years: -95.54%
• 10 years: -93.99%
• Sector: Healthcare
• Industry: Pharmaceutical Preparations

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

0.3% more ownership

Funds ownership: 30.0% [Q2] → 30.3% (+0.3%) [Q3]

0% more funds holding

Funds holding: 21 [Q2] → 21 (+0) [Q3]

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

15% less capital invested

Capital invested by funds: $6.69M [Q2] → $5.65M (-$1.03M) [Q3]

20% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 5

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $5 121% upside
• Avg. target: $5 121% upside
• High target: $5 121% upside

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

HC Wainwright & Co. Douglas Tsao 58% 1-year accuracy 68 / 118 met price target

121% upside $5

Neutral Reiterated

6 Nov 2024